Antioxidant property of Propofol in the ischemic and reperfused human skeletal muscle.
Corbucci
G G
GG
Institute of Anaesthesia and Intensive Care, University of Cagliari, Cagliari, Italy.
Marchi
A
A
Velluti
C
C
Chelo
C
C
Grella
E
E
Lettieri
B
B
D000328:Adult; D018686:Anesthetics, Intravenous / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D002374:Catalase / Q000097:blood; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D015742:Propofol / Q000627:therapeutic use*; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000473:pathology; D014527:Uric Acid / Q000097:blood
D018686:Anesthetics, Intravenous; D000975:Antioxidants; D014527:Uric Acid; D008315:Malondialdehyde; D002374:Catalase; D015742:Propofol